Latest News for: msk
Edit
MSK Prasad backs Gautam Gambhir after India’s second consecutive T20I series defeat
Cricket Country 15 Jul 2026
Edit
New MSK initiatives bring AI into everyday cancer care
The Gulf Time 14 Jul 2026
Memorial Sloan Kettering Cancer Center (MSK) is bringing artificial intelligence into two important areas of cancer care, with new work focused on clinical trial matching and predicting immunotherapy response using routine blood tests.
Edit
Portfolio News: MSK Clinics Group launches with three strategic acquisitions (Ansor LLP)
Public Technologies 03 Jul 2026
Edit
The yuan exchange rate on the Moscow Stock Exchange increased by 0.039 rubles by 10:05 MSK
AK&M Information Agency 24 Jun 2026
Edit
MSK Masters Announces Release of Sonography of the Extremities - Techniques and Protocols, 5th Edition
Nasdaq Globe Newswire 23 Jun 2026
New edition expands interactive learning resources, ...
Edit
Blue Cross launches MSK Care Pathway for growing MSK healthcare needs
Hong Kong Standard 11 Jun 2026
Edit
'You don't drop a World Cup-winning captain': MSK Prasad refuses to buy Suryakumar Yadav snub narrative
Hindustan Times 08 Jun 2026
Edit
Savills launches 82 MSK Hotel in Marylebone for £12.5 million (Savills plc)
Public Technologies 08 Jun 2026
) ... Josh O'Rourke, Director, Savills Hotel Capital Markets, comments, "We are delighted to bring the 82 MSK Hotel to market, offering investors a rare opportunity to acquire a freehold hotel in the heart of Marylebone ... Disclaimer ... (noodl.
Edit
Suryakumar Yadav is too good a player to be dropped, hope he's rested: MSK Prasad
The Times of India 06 Jun 2026
Edit
Suryakumar Yadav should continue as T20I captain, MSK Prasad urges India to groom Shreyas Iyer, ...
Zeenews 04 Jun 2026
Edit
MSK Awards and Appointments May 2026 (Memorial Sloan-Kettering Cancer Center)
Public Technologies 03 Jun 2026
Edit
MSK at ASCO: New Experimental Immunotherapy Combination Shows Promise for People with Advanced Liver Cancer (Memorial Sloan-Kettering Cancer Center)
Public Technologies 01 Jun 2026
These findings were presented by Memorial Sloan Kettering Cancer Center (MSK) at this year's annual American Society of Clinical Oncology (ASCO) meeting.
Edit
MSK at ASCO: Targeted Therapy Significantly Delays Cancer Progression in Rare, Aggressive Sarcoma (Memorial Sloan-Kettering Cancer Center)
Public Technologies 31 May 2026
An oral targeted therapy is showing promise for people with dedifferentiated liposarcoma (DDLPS), a rare subtype of soft tissue sarcoma, according to Memorial Sloan Kettering Cancer Center (MSK) physician-scientists.
- 1
- 2
- Next page »